# Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes

> **NCT04053712** · PHASE4 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 13 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** Glucagon
- **DEVICE:** Closed-loop system

## Key facts

- **NCT ID:** NCT04053712
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-16
- **Primary completion:** 2021-03-19
- **Final completion:** 2021-03-19
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-08-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053712, "Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04053712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*